August 18, 2022

New research from the University of Cincinnati,examines the barriers as well as those that are helpful in the prevention and treatment of COVID-19 in Latinx families in Cincinnati. Researchers identified primary barriers that include insecurities in food, jobs and housing and immigration. Key facilitators included having trusted messengers of health-related information.

October 20, 2022

New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).

January 18, 2023

Research from the University of Cincinnati shows people who wear tefillin, leather bands used in a Jewish religious practice which involves the tight wrapping of an arm with the bands, may receive cardiovascular health benefits. The study suggests those benefits are the result of ischemic or reduced blood flow preconditioning which produces protection from the damage caused by heart attacks.

February 15, 2022

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.

November 17, 2022

According to a report in early 2022 from the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes, which is more than 11% of the population. Diabetes was the seventh leading cause of death in the United States in 2017 based on the death certificates in which diabetes was listed as the underlying cause of death. A newly launched University of Cincinnati partnership is aiming to put a dent in those numbers in Greater Cincinnati.

February 22, 2021

Shaina Horner, a clinical researcher in the Division of Infectious Diseases used her connections in the local Latinx community to help recruit a diverse population for the Moderna COVID-19 vaccine trial.

August 25, 2022

One of the major roadblocks in the fight against the spread of COVID-19 in the early days of the pandemic was people refusing to get vaccinated against the virus. New research at UC examines that vaccine hesitancy and provides key insights into the behaviors and perceptions of the U.S. population during a critical time of the COVID-19 pandemic, just as vaccines were becoming more available.

May 23, 2023

Research out of UC examines the impact of stress during pregnancy on natal neurodevelopment. Spectrum News interviewed Anna Ruehlmann, PhD, of the Department of Environmental Health and Public Health Sciences at the UC College of Medicine about the study which she led.

November 28, 2022

A new study from the University of Cincinnati examined the impact of workplace stress and provided insights for organizations to explore ways to reduce workplace stress for a better and healthier working environment. The study had two parts: a survey in which respondents described their experiences of workplace stress during the COVID-19 pandemic and a quantitative study using saliva cortisol as a biomarker of stress along with a stress diary to find out where and when workplace stress commonly occurred.

September 21, 2022

UC is one of 36 sites part of the GRADE study comparing different diabetes medicines. The study is going to be published in the New England Journal of Medicine.